The more aggressive HER2+ tumours had higher levels of exon 9 (indicative of the FGFR2 IIIc isoform) (Figure 7), while TNBC had lower IIIb and IIIc expression levels compared to ER/PR-positive cancers (Figure 8). This evidence concerns the gene ERBB2 and neoplasm.